EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genome‐Wide Association Study of Symptom Change Following Cognitive Behavioral Therapy for Common Mental Disorders

Julia Bäckman iD, Olly Kravchenko iD, Matthew Halvorsen iD, Elles de Schipper iD, Ekaterina Ivanova iD, Viktor Kaldo iD, Nils Hentati Isacsson iD, Thorstein Olsen Eide, Kira D Höffler iD, Manuel Mattheisen iD, Bjarne Hansen iD, Gerd Kvale iD und 7 weitere

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · 2026

DOI: 10.1002/ajmg.b.70015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2026. Verfasst von Julia Bäckman und 18 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Stock…. Hauptthemen laut MEDLINE: Cognitive Behavioral Therapy, Mental Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Forskningsrådet om Hälsa, Arbetsliv och Välfärd, ALF, Center for Innovative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cognitive behavioral therapy (CBT) is a well‐established, evidence‐based treatment for common mental disorders such as depression, anxiety disorders, and obsessive‐compulsive disorder (OCD). However, treatment outcomes vary widely, and a substantial proportion of patients do not achieve sufficient improvement. Robust predictors of individual differences in symptom change are currently lacking. Genetic differences have been suggested to play a role, but existing evidence is inconclusive. This study investigated the extent to which common genetic variants—single nucleotide polymorphisms (SNPs)—contribute to variability in symptom change. The sample was derived from the MULTI‐PSYCH and NORDiC cohorts, comprising 3113 adults and children treated with CBT for depression, panic disorder, social anxiety disorder, or OCD. We performed a genome‐wide association study (GWAS) of symptom change following CBT and estimated the proportion of variance attributed to SNPs. Secondary analyses included GWAS and SNP‐based heritability estimation of additional clinically relevant outcomes: pre‐ and post‐treatment symptom severity and remission status. No variants reached genome‐wide significance. We estimated SNP‐based heritability of symptom change at = 0.221 (SE = 0.123). These results suggest that common genetic variation may contribute modestly to treatment outcomes. Much larger samples would be required to obtain more precise estimates and to detect genome‐wide significant loci.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive Behavioral TherapyMental DisordersHumansGenome-Wide Association StudyPolymorphism, Single NucleotideFemaleMaleAdultObsessive-Compulsive DisorderChildAnxiety DisordersTreatment OutcomeMiddle AgedPanic DisorderDepression

Stichwörter der Autor:innen

anxietycognitive behavioral therapydepressiongenome‐wide association studyobsessive‐compulsive disordersymptom changetreatment outcome

Autor:innen und Institutionen

  • Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
  • Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USA.
  • Department of Psychology, Faculty of Health and Life Sciences, Linnaeus University, Växjö, Sweden.
  • Bergen Center for Brain Plasticity, Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
  • Department of Psychiatry, Møre Og Romsdal Hospital Trust, Molde, Norway.
  • Center for Crisis Psychology, University of Bergen, Bergen, Norway.

ORCID-Profile: Julia Bäckman, Olly Kravchenko, Matthew Halvorsen, Elles de Schipper, Ekaterina Ivanova, Viktor Kaldo, Nils Hentati Isacsson, Kira D Höffler, Manuel Mattheisen, Bjarne Hansen, Gerd Kvale, Kristen Hagen, Jan Haavik, David Mataix-Cols, James J Crowley, John Wallert, Christian Rück

Förderung

  • Forskningsrådet om Hälsa, Arbetsliv och Välfärd
  • ALF
  • Center for Innovative Medicine
  • Vetenskapsrådet
  • Stiftelsen Söderström Königska Sjukhemmet
  • NIMH NIH HHS
  • Trond Mohn stiftelse
  • Forskningsrådet för hälsa, arbetsliv och välfärd

Zitieren

APA

Bäckman, J., Kravchenko, O., Halvorsen, M., de Schipper, E., Ivanova, E., Kaldo, V., Isacsson, N. H., Eide, T. O., Höffler, K. D., Mattheisen, M., Hansen, B., Kvale, G., Hagen, K., Haavik, J., Mataix-Cols, D., Crowley, J. J., Wallert, J., Rück, C., & Nordic OCD and Related Disorders Consortium (NORDiC) (2026). Genome‐Wide Association Study of Symptom Change Following Cognitive Behavioral Therapy for Common Mental Disorders. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. https://doi.org/10.1002/ajmg.b.70015

Vancouver

Bäckman J, Kravchenko O, Halvorsen M, de Schipper E, Ivanova E, Kaldo V, et al. Genome‐Wide Association Study of Symptom Change Following Cognitive Behavioral Therapy for Common Mental Disorders. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2026. doi:10.1002/ajmg.b.70015

BibTeX
@article{Bckman2026,
  author = {Bäckman, Julia and Kravchenko, Olly and Halvorsen, Matthew and de Schipper, Elles and Ivanova, Ekaterina and Kaldo, Viktor and Isacsson, Nils Hentati and Eide, Thorstein Olsen and Höffler, Kira D and Mattheisen, Manuel and Hansen, Bjarne and Kvale, Gerd and Hagen, Kristen and Haavik, Jan and Mataix-Cols, David and Crowley, James J and Wallert, John and Rück, Christian and Nordic OCD and Related Disorders Consortium (NORDiC), Nordic OCD and Related Disorders Consortium (NORDiC)},
  title = {Genome‐Wide Association Study of Symptom Change Following Cognitive Behavioral Therapy for Common Mental Disorders},
  journal = {American Journal of Medical Genetics Part B: Neuropsychiatric Genetics},
  year = {2026},
  doi = {10.1002/ajmg.b.70015}
}
Kostenlos starten →